According to the latest report by IMARC Group, titled “Veterinary Infectious Disease Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global veterinary infectious disease diagnostics market size reached US$ 1.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2027, exhibiting a growth rate (CAGR) of 8.8% during 2022-2027.
Veterinary infectious disease diagnostic technologies comprise cytology, immunohistochemical stains, bacteriological culture, fecal examination, and nucleic acid amplification. They assist in detecting diseases, evaluating the overall health, and providing effective treatment to animals. As it also reduces the risk of cross-contamination, they are extensively utilized in reference laboratories, veterinary clinics, and research institutes and universities across the globe.
Request Free Sample Report: https://www.imarcgroup.com/veterinary-infectious-disease-diagnostics-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The increasing adoption of companion animals on account of inflating income levels and the rising trend of nuclear families represents one of the major factors strengthening the market growth. Besides this, there is a rise in the prevalence of zoonotic diseases among animals. This, along with the growing consumption of animal-derived products and rising concerns about food safety around the world, is driving the market. Furthermore, the coronavirus disease (COVID-19) outbreak is positively influencing the demand for polymerase chain reaction (PCR) testing to analyze the impact of the infection on animals, which is impelling the market growth.
Breakup by Technology:
- Molecular Diagnostics
Breakup by Animal Type:
- Companion Animals
- Food Producing Animals
Breakup by Infection Type:
- Bacterial Infections
- Viral Infections
- Parasitic Infections
Breakup by End User:
- Reference Laboratories
- Veterinary Laboratories and Clinics
- Point of Care/In House Testing
- Research Institutes and Universities
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- Biomérieux SA
- Creative Diagnostics
- HESKA Corporation
- Innovative Diagnostics
- IDEXX Laboratories Inc
- Neogen Corporation
- Qiagen N.V
- Randox Laboratories Ltd
- Thermo Fisher Scientific Inc
Ask Analyst for Customization and Explore Full Report with TOC List of Figure: https://www.imarcgroup.com/veterinary-infectious-disease-diagnostics-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800